Precursor Cell Lymphoblastic Leukemia-Lymphoma
"Precursor Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
MeSH Number(s)
C04.557.337.428.600
C15.604.515.560.600
C20.683.515.528.600
Concept/Terms
Precursor Cell Lymphoblastic Leukemia-Lymphoma- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor Cell Lymphoblastic Leukemia Lymphoma
- Leukemia, Lymphoblastic
- Leukemia, Lymphoblastic, Acute
- Leukemia, Lymphocytic, Acute
- Lymphoma, Lymphoblastic
- Lymphoblastic Leukemia
- Lymphoblastic Leukemia, Acute
- Acute Lymphoblastic Leukemia
- Leukemia, Acute Lymphoblastic
- Lymphoblastic Lymphoma
- Lymphomas, Lymphoblastic
- Lymphocytic Leukemia, Acute
- Acute Lymphocytic Leukemia
- Leukemia, Acute Lymphocytic
- Acute Lymphoid Leukemia
- Leukemia, Acute Lymphoid
- Lymphoid Leukemia, Acute
- Leukemia, Lymphoid, Acute
Leukemia, Lymphocytic, Acute, L1- Leukemia, Lymphocytic, Acute, L1
- Lymphocytic Leukemia, L1
- L1 Lymphocytic Leukemia
- Leukemia, L1 Lymphocytic
- Lymphoblastic Leukemia, Acute, Childhood
- Lymphoblastic Leukemia, Acute, L1
- ALL, Childhood
- Childhood ALL
- Leukemia, Lymphoblastic, Acute, L1
Leukemia, Lymphocytic, Acute, L2- Leukemia, Lymphocytic, Acute, L2
- Lymphocytic Leukemia, L2
- L2 Lymphocytic Leukemia
- Leukemia, L2 Lymphocytic
- Lymphoblastic Leukemia, Acute, Adult
- Lymphoblastic Leukemia, Acute, L2
- Leukemia, Lymphoblastic, Acute, L2
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Below are MeSH descriptors whose meaning is more general than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
This graph shows the total number of publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Harvard Catalyst Profiles by year, and whether "Precursor Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 11 | 2 | 13 |
1995 | 13 | 4 | 17 |
1996 | 11 | 2 | 13 |
1997 | 15 | 4 | 19 |
1998 | 11 | 2 | 13 |
1999 | 7 | 1 | 8 |
2000 | 12 | 2 | 14 |
2001 | 13 | 3 | 16 |
2002 | 10 | 3 | 13 |
2003 | 13 | 3 | 16 |
2004 | 14 | 2 | 16 |
2005 | 17 | 4 | 21 |
2006 | 17 | 6 | 23 |
2007 | 18 | 4 | 22 |
2008 | 10 | 11 | 21 |
2009 | 19 | 2 | 21 |
2010 | 21 | 5 | 26 |
2011 | 19 | 5 | 24 |
2012 | 19 | 2 | 21 |
2013 | 19 | 3 | 22 |
2014 | 25 | 3 | 28 |
2015 | 21 | 1 | 22 |
2016 | 33 | 5 | 38 |
2017 | 25 | 5 | 30 |
2018 | 28 | 0 | 28 |
2019 | 36 | 3 | 39 |
2020 | 43 | 2 | 45 |
2021 | 44 | 2 | 46 |
2022 | 41 | 0 | 41 |
2023 | 30 | 0 | 30 |
2024 | 2 | 0 | 2 |
Below are the most recent publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.
-
Measuring neurobehavioral side effects of corticosteroids in pediatric acute lymphoblastic leukemia: A scoping review. Pediatr Blood Cancer. 2024 Apr; 71(4):e30881.
-
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols. Leukemia. 2024 Mar; 38(3):482-490.
-
Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia. Ann Hematol. 2024 Feb; 103(2):489-498.
-
SOHO State of the Art Updates and Next Questions | Approach to Older Adults With Phildadelphia-Chromosome Negative Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2024 Mar; 24(3):133-140.
-
Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial. Lancet Haematol. 2024 Jan; 11(1):e27-e37.
-
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. Clin Cancer Res. 2023 Nov 14; 29(22):4613-4626.
-
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia. J Natl Cancer Inst. 2023 10 09; 115(10):1179-1187.
-
KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study. Haematologica. 2023 10 01; 108(10):2865-2871.
-
Down syndrome and leukemia: from basic mechanisms to clinical advances. Haematologica. 2023 10 01; 108(10):2570-2581.
-
Isolated lacrimal gland enlargement as a presenting sign of relapse of B-cell acute lymphoblastic leukemia in an adult. Digit J Ophthalmol. 2023; 29(3):73-76.